Independent batch analysis
Batch Verification
Passed all tests
99.5%
Batch average by RP-HPLC
10.71 mg
Batch average across three vials
Confirmed
Compound identity result
No growth
Reported sterility result
0.09 EU/mL
LAL test result
<0.1 ppm
As 0.076 | Cd 0.031 | Pb 0.063 | Hg 0.038 ppm
Not detected
Results are specific to batch BPC-260629-G5 and should not be generalized to any other lot. Review the complete certificate for full methods and results.
Product overview
BPC-157 + TB-500 10 mg Research Blend
BPC-157 and TB-500 are discussed in scientific literature as distinct experimental peptides. BPC-157 has primarily been examined in preclinical tissue-repair models, while TB-500 is described as a synthetic peptide related to an actin-binding region of thymosin beta-4.
This Peptora blend is supplied as lyophilized powder with a total labelled quantity of 10 mg per vial. The batch certificate identifies both components but does not state their individual ratio within the 10 mg total.
Published studies listed below are provided strictly as scientific background. They do not establish that Peptora’s material is suitable for clinical use, and they are not instructions or recommendations for human or veterinary use.
Research Context at a Glance
Published scientific literature examines the two blend components through separate experimental research models:
Preclinical peptide research
Thymosin beta-4 fragment research
This summary describes the investigational mechanism reported in scientific literature. It is not a statement of intended use for this laboratory material.
Batch documentation
Traceable From Product to Certificate
The product, batch identifier and Elementrix report are presented together so researchers can review the applicable certificate before ordering.
- ✓ Batch-specific COA available online
- ✓ Direct Elementrix verification link
- ✓ Reported purity, identity and net content
Expanded third-party review
More Than a Purity Percentage
This batch certificate also reports sterility, endotoxin, heavy metals and fentanyl-presence analysis—giving researchers a broader documented testing profile than a purity-only report.
The Peptora testing difference
We Test Beyond Purity
A purity percentage is only one part of a meaningful batch review. Peptora commissioned an expanded third-party panel so researchers can examine identity, content and selected quality indicators – all tied to one independently verifiable batch certificate.
✓ Net content
✓ LC-MS identity
✓ Sterility
✓ Endotoxin
✓ Heavy metals
✓ Fentanyl presence
One batch-specific Elementrix certificate with direct verification.
What the expanded panel covers
Purity and content
RP-HPLC purity and average net content are reported for the batch, including individual results from three sampled vials.
Identity confirmation
LC-MS analysis is reported as confirming the identity of the material evaluated by Elementrix.
Sterility and endotoxin
The certificate reports no growth for sterility and an endotoxin result of 0.09 EU/mL.
Heavy-metals screening
Arsenic, cadmium, lead and mercury results are itemized (As 0.076, Cd 0.031, Pb 0.063 and Hg 0.038 ppm), with heavy metals reported below 0.1 ppm.
Fentanyl-presence analysis
Additional fentanyl-presence analysis is included on the certificate with a result of not detected.
Direct verification
The report number can be checked through Elementrix so the published certificate is not dependent on Peptora’s description alone.
Product care and fulfilment
Storage and Shipping
Storage
The Elementrix certificate for this batch does not state a storage temperature. Follow the product packaging and your laboratory’s validated storage and handling protocol.
Do not use the vial if its packaging or integrity appears compromised.
Ships from Ontario
Orders are fulfilled from Ontario, Canada. Review Peptora’s shipping information for current processing, delivery and order-handling details.
Documentation built in
Why Choose Peptora?
Peptora Peptide Labs is structured around transparent, batch-specific documentation for Canadian laboratory researchers.
Independent analysis
Testing results are documented through a third-party Elementrix certificate rather than an internal specification sheet alone.
Batch-specific COAs
The displayed certificate is tied to a defined report number and batch identifier for straightforward traceability.
Direct verification
Researchers can open the complete PDF and follow the independent verification link from the product page.
Canadian fulfilment
This research material ships from Ontario, Canada.
Clear intended use
Product presentation and documentation clearly identify the material as intended only for laboratory research.
Accessible documentation
Testing standards, certificates and product information are organized for review before ordering.
Product questions
Frequently Asked Questions
Clear answers about this BPC-157 + TB-500 10 mg research blend, its batch documentation, independent testing and intended use.
Important product restriction
For Laboratory Research Use Only
All Peptora Peptide Labs products are intended solely for controlled laboratory research. This material is not for human or veterinary consumption and is not intended for compounding, clinical use, diagnosis, treatment, cure or prevention of disease.
Peptora does not provide medical advice, dosing instructions, administration guidance or treatment recommendations.
Scientific background references
- Gwyer D, et al. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell and Tissue Research. 2019.
- Chang CH, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology. 2011.
- Ho ENM, et al. Doping control analysis of TB-500, a synthetic version of an active region of thymosin beta-4, in equine urine and plasma. Drug Testing and Analysis. 2012.
- Goldstein AL, et al. Thymosin beta-4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opinion on Biological Therapy. 2012.
References are provided for scientific background only. Published clinical research does not validate this specific Peptora batch or authorize use of this product in humans or animals.
